Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax

IQVIA HOLDINGS INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax

IQVIA HOLDINGS INC. (IQV) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax of -$7.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax · last filed 2026-05-05

  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2026-03-31 was -$7.00M.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-12-31 was $4.00M, a 33.33% increase year-over-year.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-09-30 was $3.00M, a 62.50% decline year-over-year.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-06-30 was $2.00M, a 81.82% decline year-over-year.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2025 was $8.00M, a 74.19% decline from fiscal 2024.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2024 was $31.00M, a 39.22% decline from fiscal 2023.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2023 was $51.00M.
  • IQVIA HOLDINGS INC. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2022 was -$10.00M.
Period endOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 3 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 6 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 9 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 12 month
2026-03-31-$7.00M
10-Q · filed 2026-05-05
-$3.00M
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
$2.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$7.00M
derived: sum of 2 quarters · filed 2026-02-17
$9.00M
derived: sum of 3 quarters · filed 2026-02-17
$8.00M
10-K · filed 2026-02-17
2025-09-30$3.00M
10-Q · filed 2025-10-28
$5.00M
derived: sum of 2 quarters · filed 2025-10-28
$4.00M
10-Q · filed 2025-10-28
$7.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30$2.00M
10-Q · filed 2025-07-22
$1.00M
10-Q · filed 2025-07-22
$4.00M
derived: sum of 3 quarters · filed 2026-05-05
$12.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31-$1.00M
10-Q · filed 2026-05-05
$2.00M
derived: sum of 2 quarters · filed 2026-05-05
$10.00M
derived: sum of 3 quarters · filed 2026-05-05
$21.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$11.00M
derived: sum of 2 quarters · filed 2026-02-17
$22.00M
derived: sum of 3 quarters · filed 2026-02-17
$31.00M
10-K · filed 2026-02-17
2024-09-30$8.00M
10-Q · filed 2025-10-28
$19.00M
derived: sum of 2 quarters · filed 2025-10-28
$28.00M
10-Q · filed 2025-10-28
$38.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$11.00M
10-Q · filed 2025-07-22
$20.00M
10-Q · filed 2025-07-22
$30.00M
derived: sum of 3 quarters · filed 2026-02-17
$39.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31$9.00M
10-Q · filed 2025-05-06
$19.00M
derived: sum of 2 quarters · filed 2026-02-17
$28.00M
derived: sum of 3 quarters · filed 2026-02-17
$35.00M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$19.00M
derived: sum of 2 quarters · filed 2026-02-17
$26.00M
derived: sum of 3 quarters · filed 2026-02-17
$51.00M
10-K · filed 2026-02-17
2023-09-30$9.00M
10-Q · filed 2024-10-31
$16.00M
derived: sum of 2 quarters · filed 2024-10-31
$41.00M
10-Q · filed 2024-10-31
$45.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$7.00M
10-Q · filed 2024-07-22
$32.00M
10-Q · filed 2024-07-22
$36.00M
derived: sum of 3 quarters · filed 2025-02-13
$35.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$25.00M
10-Q · filed 2024-05-02
$29.00M
derived: sum of 2 quarters · filed 2025-02-13
$28.00M
derived: sum of 3 quarters · filed 2025-02-13
$14.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$3.00M
derived: sum of 2 quarters · filed 2025-02-13
-$11.00M
derived: sum of 3 quarters · filed 2025-02-13
-$10.00M
10-K · filed 2025-02-13
2022-09-30-$1.00M
10-Q · filed 2023-11-01
-$15.00M
derived: sum of 2 quarters · filed 2023-11-01
-$14.00M
10-Q · filed 2023-11-01
-$19.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30-$14.00M
10-Q · filed 2023-08-01
-$13.00M
10-Q · filed 2023-08-01
-$18.00M
derived: sum of 3 quarters · filed 2024-02-15
-$21.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$1.00M
10-Q · filed 2023-04-28
-$4.00M
derived: sum of 2 quarters · filed 2024-02-15
-$7.00M
derived: sum of 3 quarters · filed 2024-02-15
-$10.00M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31-$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
-$8.00M
derived: sum of 2 quarters · filed 2024-02-15
-$11.00M
derived: sum of 3 quarters · filed 2024-02-15
-$12.00M
10-K · filed 2024-02-15
2021-09-30-$3.00M
10-Q · filed 2022-10-27
-$6.00M
derived: sum of 2 quarters · filed 2022-10-27
-$7.00M
10-Q · filed 2022-10-27
-$11.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30-$3.00M
10-Q · filed 2022-07-22
-$4.00M
10-Q · filed 2022-07-22
-$8.00M
derived: sum of 3 quarters · filed 2023-02-15
-$10.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31-$1.00M
10-Q · filed 2022-04-28
-$5.00M
derived: sum of 2 quarters · filed 2023-02-15
-$7.00M
derived: sum of 3 quarters · filed 2023-02-15
$5.00M
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
-$6.00M
derived: sum of 2 quarters · filed 2023-02-15
$6.00M
derived: sum of 3 quarters · filed 2023-02-15
-$10.00M
10-K · filed 2023-02-15
2020-09-30-$2.00M
10-Q · filed 2021-10-22
$10.00M
derived: sum of 2 quarters · filed 2021-10-22
-$6.00M
10-Q · filed 2021-10-22
-$7.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$12.00M
10-Q · filed 2021-07-28
-$4.00M
10-Q · filed 2021-07-28
-$5.00M
derived: sum of 3 quarters · filed 2022-02-16
-$7.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31-$16.00M
10-Q · filed 2021-04-23
-$17.00M
derived: sum of 2 quarters · filed 2022-02-16
-$19.00M
derived: sum of 3 quarters · filed 2022-02-16
-$16.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$3.00M
derived: sum of 2 quarters · filed 2022-02-16
$0.00
derived: sum of 3 quarters · filed 2022-02-16
$1.00M
10-K · filed 2022-02-16
2019-09-30-$2.00M
10-Q · filed 2020-10-22
$1.00M
derived: sum of 2 quarters · filed 2020-10-22
$2.00M
10-Q · filed 2020-10-22
2019-06-30$3.00M
10-Q · filed 2020-07-23
$4.00M
10-Q · filed 2020-07-23
2019-03-31$1.00M
10-Q · filed 2020-04-30
2018-12-31$12.00M
10-K · filed 2021-02-12
2018-06-30$1.00M
10-Q · filed 2019-07-24
$0.00
derived: sum of 2 quarters · filed 2019-07-24
2018-03-31-$1.00M
10-Q · filed 2019-05-02
2017-12-31$1.00M
10-K · filed 2020-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B